Nifty
Sensex
:
:
23349.90
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 524742 | NSE: CAPLIPOINT

1456.20
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1430.00
  •  1465.95
  •  1422.10
  •  1431.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  127153
  •  1839.51
  •  2176.75
  •  1178.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,761.09
  • 29.91
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 14,227.51
  • 0.26%
  • 5.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.56%
  • 0.99%
  • 17.12%
  • FII
  • DII
  • Others
  • 3.71%
  • 1.77%
  • 5.85%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 14.44
  • 10.10

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 16.22
  • 6.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 16.28
  • 15.09

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.89
  • 18.63
  • 20.10

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.90
  • 4.02
  • 4.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.54
  • 12.93
  • 14.14

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
483.10
410.06
17.81%
458.96
395.32
16.10%
453.22
389.28
16.43%
435.50
372.07
17.05%
Expenses
318.34
272.66
16.75%
307.15
268.79
14.27%
307.99
265.35
16.07%
293.22
262.70
11.62%
EBITDA
164.76
137.40
19.91%
151.81
126.53
19.98%
145.23
123.93
17.19%
142.28
109.37
30.09%
EBIDTM
34.10%
33.51%
33.08%
32.01%
32.04%
31.84%
32.67%
29.39%
Other Income
20.77
20.43
1.66%
18.56
12.04
54.15%
17.29
11.40
51.67%
17.18
14.15
21.41%
Interest
0.21
0.18
16.67%
0.05
0.28
-82.14%
0.15
0.23
-34.78%
0.17
0.36
-52.78%
Depreciation
16.76
11.76
42.52%
15.96
11.38
40.25%
16.40
11.13
47.35%
13.90
11.43
21.61%
PBT
168.56
145.89
15.54%
154.36
126.91
21.63%
145.97
123.97
17.75%
145.39
111.73
30.13%
Tax
37.65
29.86
26.09%
29.46
22.76
29.44%
24.80
22.81
8.72%
25.59
14.35
78.33%
PAT
130.91
116.03
12.82%
124.90
104.15
19.92%
121.17
101.16
19.78%
119.80
97.38
23.02%
PATM
27.10%
28.30%
27.21%
26.35%
26.74%
25.99%
27.51%
26.17%
EPS
17.21
15.12
13.82%
16.31
13.62
19.75%
16.01
13.45
19.03%
15.43
12.84
20.17%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Net Sales
1,830.78
1,694.10
1,466.73
1,269.41
1,061.29
863.20
648.69
539.84
401.65
238.72
251.77
Net Sales Growth
16.85%
15.50%
15.54%
19.61%
22.95%
33.07%
20.16%
34.41%
68.25%
-5.18%
 
Cost Of Goods Sold
755.78
724.18
663.21
557.51
471.74
413.16
288.78
238.18
184.93
121.16
135.62
Gross Profit
1,075.00
969.92
803.52
711.90
589.55
450.04
359.91
301.66
216.72
117.56
116.15
GP Margin
58.72%
57.25%
54.78%
56.08%
55.55%
52.14%
55.48%
55.88%
53.96%
49.25%
46.13%
Total Expenditure
1,226.70
1,142.65
1,026.21
874.88
737.04
603.13
416.84
344.52
276.84
174.51
192.06
Power & Fuel Cost
-
33.57
25.53
21.40
16.36
14.81
13.76
10.98
9.91
7.56
8.61
% Of Sales
-
1.98%
1.74%
1.69%
1.54%
1.72%
2.12%
2.03%
2.47%
3.17%
3.42%
Employee Cost
-
142.66
136.12
114.74
101.97
67.15
45.58
37.61
29.71
17.92
18.24
% Of Sales
-
8.42%
9.28%
9.04%
9.61%
7.78%
7.03%
6.97%
7.40%
7.51%
7.24%
Manufacturing Exp.
-
117.73
90.99
82.01
69.85
68.23
43.49
37.11
28.56
14.33
16.04
% Of Sales
-
6.95%
6.20%
6.46%
6.58%
7.90%
6.70%
6.87%
7.11%
6.00%
6.37%
General & Admin Exp.
-
89.41
85.38
66.68
38.53
25.50
20.82
12.27
13.78
8.15
7.97
% Of Sales
-
5.28%
5.82%
5.25%
3.63%
2.95%
3.21%
2.27%
3.43%
3.41%
3.17%
Selling & Distn. Exp.
-
28.44
18.78
27.52
18.03
9.95
2.08
5.92
9.41
2.29
2.85
% Of Sales
-
1.68%
1.28%
2.17%
1.70%
1.15%
0.32%
1.10%
2.34%
0.96%
1.13%
Miscellaneous Exp.
-
6.66
6.20
5.02
20.56
4.33
2.33
2.45
0.55
3.10
2.85
% Of Sales
-
0.39%
0.42%
0.40%
1.94%
0.50%
0.36%
0.45%
0.14%
1.30%
1.08%
EBITDA
604.08
551.45
440.52
394.53
324.25
260.07
231.85
195.32
124.81
64.21
59.71
EBITDA Margin
33.00%
32.55%
30.03%
31.08%
30.55%
30.13%
35.74%
36.18%
31.07%
26.90%
23.72%
Other Income
73.80
66.94
56.52
38.89
27.93
41.33
19.03
12.67
9.96
3.66
3.03
Interest
0.58
0.78
0.78
0.70
1.59
0.32
0.58
0.61
0.52
0.34
0.97
Depreciation
63.02
53.44
44.99
46.90
36.97
31.62
23.43
19.00
13.30
7.48
8.38
PBT
614.28
564.17
451.27
385.82
313.62
269.46
226.88
188.38
120.95
60.05
53.39
Tax
117.50
103.01
74.36
77.37
62.19
54.38
50.32
43.74
25.44
14.28
12.26
Tax Rate
19.13%
18.26%
16.48%
20.05%
19.83%
20.18%
22.18%
23.22%
21.03%
23.78%
22.96%
PAT
496.78
457.09
376.26
299.84
242.27
215.00
176.56
144.78
95.61
45.77
41.04
PAT before Minority Interest
493.56
461.42
376.99
308.45
251.43
215.08
176.56
144.63
95.50
45.77
41.13
Minority Interest
-3.22
-4.33
-0.73
-8.61
-9.16
-0.08
0.00
0.15
0.11
0.00
-0.09
PAT Margin
27.13%
26.98%
25.65%
23.62%
22.83%
24.91%
27.22%
26.82%
23.80%
19.17%
16.30%
PAT Growth
18.64%
21.48%
25.49%
23.76%
12.68%
21.77%
21.95%
51.43%
108.89%
11.53%
 
EPS
65.37
60.14
49.51
39.45
31.88
28.29
23.23
19.05
12.58
6.02
5.40

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Shareholder's Funds
2,315.71
1,880.48
1,483.93
1,185.83
947.91
632.91
363.83
224.76
128.14
93.19
Share Capital
89.77
89.76
89.74
89.71
89.71
51.05
15.12
15.12
15.11
15.11
Total Reserves
2,211.72
1,775.35
1,378.74
1,081.33
848.76
575.01
345.42
209.56
111.40
78.08
Non-Current Liabilities
7.46
2.13
12.55
17.39
24.86
23.42
27.86
19.90
13.69
10.39
Secured Loans
0.00
0.00
0.00
0.00
0.02
0.29
0.32
0.48
0.73
0.88
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
8.61
7.78
8.48
5.69
5.23
0.13
0.00
0.40
1.63
0.82
Current Liabilities
331.28
268.00
207.68
142.85
144.32
86.11
108.67
113.36
125.04
124.97
Trade Payables
209.41
152.56
155.94
88.50
64.14
60.47
94.23
78.60
55.71
41.56
Other Current Liabilities
110.50
99.94
48.68
51.87
79.28
24.20
13.86
33.09
60.39
72.11
Short Term Borrowings
0.28
3.41
0.50
0.00
0.00
0.00
0.00
0.00
0.00
0.05
Short Term Provisions
11.09
12.09
2.56
2.48
0.91
1.44
0.58
1.67
8.94
11.25
Total Liabilities
2,685.57
2,177.40
1,730.11
1,363.61
1,125.75
742.52
500.45
358.38
267.14
228.82
Net Block
452.66
279.81
286.57
305.34
272.50
226.84
169.48
151.83
144.23
113.13
Gross Block
702.31
480.32
445.74
422.58
354.79
271.51
231.79
195.15
180.76
142.71
Accumulated Depreciation
249.65
200.51
159.17
117.24
82.29
44.67
62.31
43.31
36.53
29.58
Non Current Assets
792.65
625.21
432.29
349.04
303.23
248.83
196.34
179.16
148.61
146.95
Capital Work in Progress
116.62
220.71
17.73
13.88
20.12
9.70
15.29
3.42
0.23
30.63
Non Current Investment
137.63
70.52
37.01
0.66
0.56
0.33
0.33
13.24
0.44
0.45
Long Term Loans & Adv.
78.31
51.51
89.90
7.92
10.05
11.95
11.23
10.67
3.71
2.75
Other Non Current Assets
7.43
2.66
1.08
21.24
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
1,892.92
1,552.19
1,297.82
1,014.57
822.53
493.69
304.11
179.22
118.53
81.87
Current Investments
237.98
210.18
51.97
10.54
60.23
69.62
46.34
4.20
0.00
0.00
Inventories
363.04
288.22
227.31
179.01
238.23
37.45
28.46
22.29
18.81
13.66
Sundry Debtors
542.72
394.06
317.05
279.36
228.96
159.81
125.88
33.02
7.95
5.66
Cash & Bank
552.74
493.48
462.99
438.33
223.43
152.99
79.28
93.07
68.10
45.37
Other Current Assets
196.44
22.82
13.61
20.25
71.68
73.83
24.16
26.63
23.67
17.18
Short Term Loans & Adv.
146.01
143.43
224.89
87.08
56.81
64.61
17.28
19.31
12.58
11.08
Net Current Assets
1,561.64
1,284.19
1,090.14
871.72
678.21
407.58
195.44
65.86
-6.51
-43.10
Total Assets
2,685.57
2,177.40
1,730.11
1,363.61
1,125.76
742.52
500.45
358.38
267.14
228.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Cash From Operating Activity
318.39
271.37
336.73
268.61
44.68
83.42
66.49
67.61
42.40
49.88
PBT
564.43
451.35
385.82
313.62
269.46
226.88
188.38
120.95
60.05
53.39
Adjustment
2.40
11.77
30.44
23.09
7.09
19.12
14.84
8.61
3.87
6.21
Changes in Working Capital
-139.44
-103.75
1.96
-1.96
-177.11
-120.06
-100.38
-38.39
-5.13
1.96
Cash after chg. in Working capital
427.39
359.37
418.22
334.75
99.44
125.94
102.84
91.16
58.78
61.56
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-109.00
-88.00
-81.49
-66.14
-54.76
-42.51
-36.35
-23.55
-16.38
-11.67
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-320.04
-217.58
-376.77
-29.44
-54.50
-100.46
-69.02
-36.11
-5.72
-22.66
Net Fixed Assets
-18.39
-56.57
-3.66
-35.46
-43.65
58.45
-48.43
-19.56
-7.66
-25.72
Net Investments
-99.00
-220.45
-115.52
46.59
-27.53
-120.03
-29.43
-17.35
0.01
-0.90
Others
-202.65
59.44
-257.59
-40.57
16.68
-38.88
8.84
0.80
1.93
3.96
Cash from Financing Activity
-38.07
-28.17
-40.68
-23.98
79.77
89.79
-11.60
-6.74
-13.95
-8.67
Net Cash Inflow / Outflow
-39.72
25.62
-80.72
215.19
69.94
72.76
-14.13
24.76
22.73
18.55
Opening Cash & Equivalents
177.56
150.76
231.57
220.77
150.65
77.17
91.31
66.55
45.37
26.82
Closing Cash & Equivalent
138.55
170.92
150.76
435.72
220.77
150.65
77.17
91.31
68.10
45.37

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Jun 15
Book Value (Rs.)
293.21
235.91
183.89
144.94
114.21
78.03
47.69
29.73
16.25
11.84
ROA
18.98%
19.30%
19.94%
20.20%
23.02%
28.41%
33.68%
30.54%
18.46%
20.12%
ROE
22.97%
23.68%
24.77%
25.65%
29.58%
37.14%
49.43%
54.97%
43.13%
55.78%
ROCE
26.92%
26.85%
28.77%
28.82%
33.35%
45.59%
64.08%
69.03%
55.41%
71.11%
Fixed Asset Turnover
2.87
3.17
2.92
2.73
2.76
2.58
2.53
2.14
1.48
1.89
Receivable days
100.92
88.48
85.74
87.41
82.19
80.37
53.72
18.62
10.40
4.17
Inventory Days
70.16
64.15
58.42
71.75
58.28
18.54
17.16
18.68
24.83
17.00
Payable days
91.22
84.89
80.02
59.05
28.33
65.76
89.68
88.17
103.48
69.75
Cash Conversion Cycle
79.85
67.73
64.14
100.11
112.15
33.15
-18.80
-50.88
-68.24
-48.58
Total Debt/Equity
0.00
0.00
0.00
0.01
0.04
0.00
0.00
0.00
0.02
0.02
Interest Cover
724.63
579.65
552.17
198.25
843.86
391.22
309.72
235.08
179.35
56.11

News Update:


  • ANVISA-Brazil concludes inspection at manufacturing facility of Caplin Point’s arm
    17th Aug 2024, 16:29 PM

    The inspection was conducted between August 12 and 16, 2024 and concluded with zero observations

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.